106 related articles for article (PubMed ID: 17888506)
1. Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice.
Senn R; Keren O; Hefetz A; Sarne Y
Pharmacol Biochem Behav; 2008 Jan; 88(3):230-7. PubMed ID: 17888506
[TBL] [Abstract][Full Text] [Related]
2. Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.
Assaf F; Fishbein M; Gafni M; Keren O; Sarne Y
Behav Brain Res; 2011 Jun; 220(1):194-201. PubMed ID: 21315768
[TBL] [Abstract][Full Text] [Related]
3. Long-term consequences of a single treatment of mice with an ultra-low dose of Delta9-tetrahydrocannabinol (THC).
Amal H; Fridman-Rozevich L; Senn R; Strelnikov A; Gafni M; Keren O; Sarne Y
Behav Brain Res; 2010 Jan; 206(2):245-53. PubMed ID: 19766676
[TBL] [Abstract][Full Text] [Related]
4. Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage.
Fishbein-Kaminietsky M; Gafni M; Sarne Y
J Neurosci Res; 2014 Dec; 92(12):1669-77. PubMed ID: 25042014
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
Nava F; Carta G; Colombo G; Gessa GL
Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
7. A single low dose of tetrahydrocannabinol induces long-term cognitive deficits.
Tselnicker I; Keren O; Hefetz A; Pick CG; Sarne Y
Neurosci Lett; 2007 Jan; 411(2):108-11. PubMed ID: 17092651
[TBL] [Abstract][Full Text] [Related]
8. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
Rodríguez G; Neugebauer NM; Yao KL; Meltzer HY; Csernansky JG; Dong H
Pharmacol Biochem Behav; 2017 Aug; 159():6-11. PubMed ID: 28648819
[TBL] [Abstract][Full Text] [Related]
9. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
10. Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline.
Varvel SA; Anum E; Niyuhire F; Wise LE; Lichtman AH
Psychopharmacology (Berl); 2005 Mar; 178(2-3):317-27. PubMed ID: 15322725
[TBL] [Abstract][Full Text] [Related]
11. Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss.
Avraham Y; Ben-Shushan D; Breuer A; Zolotarev O; Okon A; Fink N; Katz V; Berry EM
Pharmacol Biochem Behav; 2004 Apr; 77(4):675-84. PubMed ID: 15099912
[TBL] [Abstract][Full Text] [Related]
12. Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.
Winsauer PJ; Filipeanu CM; Bailey EM; Hulst JL; Sutton JL
Pharmacol Biochem Behav; 2012 Sep; 102(3):442-9. PubMed ID: 22705493
[TBL] [Abstract][Full Text] [Related]
13. Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze.
Huang P; Liu-Chen LY; Kirby LG
Neurosci Lett; 2010 May; 475(3):165-8. PubMed ID: 20363293
[TBL] [Abstract][Full Text] [Related]
14. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
[TBL] [Abstract][Full Text] [Related]
16. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
17. Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.
Fishbein M; Gov S; Assaf F; Gafni M; Keren O; Sarne Y
Exp Brain Res; 2012 Sep; 221(4):437-48. PubMed ID: 22821081
[TBL] [Abstract][Full Text] [Related]
18. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.
Valjent E; Maldonado R
Psychopharmacology (Berl); 2000 Jan; 147(4):436-8. PubMed ID: 10672638
[TBL] [Abstract][Full Text] [Related]
19. Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.
Egashira N; Ishigami N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):499-506. PubMed ID: 18029074
[TBL] [Abstract][Full Text] [Related]
20. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice.
Da S; Takahashi RN
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):321-5. PubMed ID: 11817511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]